Development of <i>6H</i>-Chromeno[3,4-<i>c</i>]pyrido[3',2':4,5]thieno[2,3-e]pyridazin-6-ones as Par-4 Secretagogues.

Development of 6H-Chromeno[3,4-c]pyrido[3',2':4,5]thieno[2,3-e]pyridazin-6-ones as Par-4 Secretagogues.

Frasinyuk, Mykhaylo S; Bondarenko, Svitlana P; Sviripa, Vitaliy M; Burikhanov, Ravshan; Rangnekar, Vivek M; Liu, Chunming; Watt, David S.

Afiliação

Frasinyuk MS; Institute of Bioorganic Chemistry and Petrochemistry, National Academy of Science of Ukraine, Kyiv 02094, Ukraine.
Bondarenko SP; Taras Shevchenko Kyiv National University, Kyiv 01033, Ukraine.
Sviripa VM; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40536-0509, United States ; Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0596, United States.
Burikhanov R; Department of Radiation Medicine, College of Medicine; University of Kentucky, Lexington, KY 40536-0096, United States.
Rangnekar VM; Department of Radiation Medicine, College of Medicine; University of Kentucky, Lexington, KY 40536-0096, United States ; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, KY 40536-0093, United States.
Liu C; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40536-0509, United States ; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, KY 40536-0093, United States.
Watt DS; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40536-0509, United States ; Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0596, United States ; Lucille Parker Markey Ca

Tetrahedron Lett ; 56(23): 3382-3384, 2015 Jun 03.

Article em En | MEDLINE | ID: mdl-26236052